Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02792725
Title Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Eli Lilly and Company
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Pacific Cancer Care Monterey California 93940 United States Details
UCLA Medical Center Santa Monica California 90404 United States Details
Orlando Health, Inc Orlando Florida 32806 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of Minnesota Medical Center, Fairview Lakes Wyoming Minnesota 55092 United States Details
Saint Luke's Cancer Institute Kansas City Missouri 64111 United States Details
Memorial Sloan Kettering Cancer Center Commack New York 11725 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
West Virginia University Hospital Morgantown West Virginia 26506 United States Details
*Shaded cells indicate that there was no data available from for the field